掃碼開始閱讀

(相關(guān)資料圖)

Scan to preview the contents.

Pharma Sources Insight April 2023 focuses on the following topics

SPONSORED BY

-ZHEJIANG JIANGBEI PHARMACEUTICAL CO., LTD

FROM THE EDITOR

-Trends in Approval of Traditional Chinese Medicines

BRAND STORY

-Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic media supplier for industrial scale production

APIs

-Against Liver Cancer, Statins Help Novel Liver Cancer Drug Development

-How Africa, Asia Could Benefit from Ticagrelor’s WHO Listing

-Proposal to Have Empagliflozin API as Option for Children with Type 2 Diabetes

PHARMACEUTICAL R&D

-Research Progress in Signaling Pathway and Related Drugs of Target GDF15

-Global Diabetes Market Outlook

PARMA IN CHINA

-Popular Products and Companies at PharmaSources.com

-The Increasing ADC+CDMO Industry Collaboration

INDUSTRY INSIGHT

-FDA"s Approval was Postponed Again, Chinese Innovative Pharmaceutical Companies Extend Their Businesses to the Middle East and North Africa

-Powered by AI, OpenAI Technology Promises a New Technological Revolution of Drug R&D

-Pharma Co-packaging Regulations

About Pharma Sources Insight

Pharma Sources Insight is a unique source of updated coverages on current eventsand deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with the leading drug-manufacturers in China which further affect the world.

Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectivesof ourexpert writersinto crucial aspects of the pharmaceutical field, all under PharmaSources.comand CPHI & PMEC China.

往期回顧

第九期：

https://flbook.com.cn/c/LQXB6v43Qi

點擊鏈接，免費閱讀第九期

第八期：

https://flbook.com.cn/c/8RGEA8j7j0

Pharma Sources Insight,

Your FREE source of news and insights into China pharmaceutical industry,

and more!

關(guān)鍵詞